Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q4J904

Entry ID Method Resolution Chain Position Source
AF-Q4J904-F1 Predicted AlphaFoldDB

No variants for Q4J904

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q4J904

No associated diseases with Q4J904

2 regional properties for Q4J904

Type Name Position InterPro Accession
domain DALR anticodon binding 502 - 618 IPR008909
domain Arginyl-tRNA synthetase, catalytic core domain 97 - 461 IPR035684

Functions

Description
EC Number 6.1.1.19 Ligases forming aminoacyl-tRNA and related compounds
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
arginine-tRNA ligase activity Catalysis of the reaction: ATP + L-arginine + tRNA(Arg) = AMP + diphosphate + L-arginyl-tRNA(Arg).
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

1 GO annotations of biological process

Name Definition
arginyl-tRNA aminoacylation The process of coupling arginine to arginyl-tRNA, catalyzed by arginyl-tRNA synthetase. The arginyl-tRNA synthetase is a class-I synthetase. The activated amino acid is transferred to the 2'-OH group of an alanine accetping tRNA. The 2'-O-aminoacyl-tRNA will ultimately migrate to the 3' position via transesterification.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNPIRSVKEE FCEIVANGLG ISKDVIFKTL EYPPREELGD ISLPLPSLKL NVRTEVTFSH
70 80 90 100 110 120
GKLIKEVRKT GIYVNAFVDE KELFKLLFTE MQDDYGVEKT ENPKRIVVEH TSANPIHPLH
130 140 150 160 170 180
IGHLRNSILG DTISRMLKIR GHDVNRRFYV NDAGRQVAIL TLGYILLGEP EPSPKVDHWF
190 200 210 220 230 240
GLIYSITNVI IEIRELKEEL KKDLDPDTYK DKINRLDELV ATAQSLRERN PEFFDKLADA
250 260 270 280 290 300
INSIPDVESE IQKIIKSYEK GDDPKIKQIV RKIVNLNLDG FRESLDKLEI SFDVYDYESE
310 320 330 340 350 360
LLWSGMVDEI LSKAFQIAKD YKGTKALELE DINEKIKEIL NIPKGLKLPP LVLTRSDGTS
370 380 390 400 410 420
LYTTRDIAYT VKKFSDFKAD TVINVIAEQQ SIPQMQLRAS LYLLGYERLA QNLVHYSYGM
430 440 450 460 470 480
VNLQGMRMSG RLGRFISLDD VIEKVSEVAK KKIEEKSGDI TNLRDIVNSA IRYAILSVAS
490 500 510 520 530 540
NKPVTFNINN IVDFEQNSGP YLQYTYARAY NILAKNQDEI KLTDADLSDL IGDKRRLLLL
550 560 570 580 590 600
IARFPETFNK AIDELRPEDL IDFLRRTADV FNRWYNFERV LQEPDYRKRI TRLFIVKGIE
610
RVLYNGLNAL GIKPLSKM